TROG Cancer Research
Members Login   CQMS Login

Lung trials now recruiting patients

Our lung cancer trials are focused on the benefits and side effects of radiotherapy.

TROG 17.02 (OUTRUN) - The aim of this study is to compare the effects of Osimertinib alone versus Osimertinib plus Stereotactic Radiosurgery (SRS) on intra-cranial disease control in EGFR mutated NSCLC with brain metastases diagnosed or developed while on first line EGFR tyrosine kinase inhibitors.

Primary sponsor: TROG


We are thankful to our 14,500 patients who have participated in our research. Please continue the generous support.